Back

Implication of myocardial perfusion abnormalities on clinical outcomes in patients undergoing percutaneous coronary intervention for chronic total occlusions

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Prognosis post-acute coronary syndromes Noninvasive Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Jesper Boes Henningsen

Aalborg (Denmark)

7 More presentations in this session

Presentation thumbnail
Temporal trends in octo- and nonagenarians with ST-elevation-myocardial infarctions and impact of interventional results on prognosis
Doctor J. Schmucker (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Impact of female gender on prevalence rates, interventional strategies and prognosis in patients admitted with ST-elevation-myocardial infarction complicated by cardiogenic shock
Doctor A. Fach (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Pre-myocardial infarction symptom and short- and long-term cardiovascular mortality among acute myocardial infarction patients
Doctor S. Inaba (Shizuoka, JP)
Abstract Slides Video
Presentation thumbnail
Direct versus late maxLCBI4mm changes after paclitaxel-coated balloon treatment of lipid-rich plaques
Ms T. Dijkstra (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Fatal and non-fatal myocardial infarction in patients with possible angina referred for rapid outpatient assessment
Doctor M. Mcdermott (Edinburgh, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis post-acute coronary syndromes

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
A predictors for 10-year mortality and clinical events in patients with chronic coronary total occlusion lesion
thumbnail
Congress Presentation
Non-invasive imaging to guide percutaneous coronary revascularization in chronic total occlusion: a systematic review and meta-analysis
thumbnail
Congress Presentation
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in the ISCHEMIA trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources